Effect of providing a formula supplemented with long-chain polyunsaturated fatty acids on immunity in full-term neonates
- PMID: 17640422
- DOI: 10.1017/S0007114507791845
Effect of providing a formula supplemented with long-chain polyunsaturated fatty acids on immunity in full-term neonates
Abstract
To determine the effect of feeding formula containing long-chain PUFA (LCP) on immune function, healthy term infants were randomised at age 2 weeks to either a standard term formula (Formula; n 14) or the same formula supplemented with the LCP 20 : 4n-6 and 22 : 6n-3 (Formula+LCP; n 16). Peripheral blood was collected at 2 and 6 weeks to measure immune cell response (the rate of [3H]thymidine uptake and cytokine production after stimulation with phytohaemagglutinin (PHA)). Compared with cells from infants receiving only human milk (HM), the rate of [3H]thymidine uptake in response to PHA, but not IL-2 production, was lower for Formula+LCP infants (P < 0.05). Compared with HM-fed infants, Formula-fed infants (but not Formula+LCP infants) produced more TNF-alpha (unstimulated) and had a fewer CD3+CD44+ cells before stimulation and fewer CD11c+ cells post-stimulation (P < 0.05). However, compared with Formula-fed infants, the Formula+LCP infants had an immune cell distribution (higher percentage CD3+CD44+ and CD4+CD28+ cells) and cytokine profile (lower production of TNF-alpha post-stimulation) that did not differ from HM infants. Additionally, it was found that feeding infants formula during the first 10 d of life influenced immune function. These infants had a higher percentage of CD3+, CD4+CD28+, and lower percentage of CD14+ cells and produced more TNF-alpha and interferon-gamma after PHA stimulation than HM-fed infants (P < 0.05). These results demonstrate that early diet influences both the presence of specific cell types and function of infant blood immune cells. Since many diseases have a strong immunological component, these immune changes may be of physiological importance to the developing infant.
Similar articles
-
Plasma fatty-acid composition and antioxidant capacity in low birth-weight infants fed formula enriched with n-6 and n-3 long-chain polyunsaturated fatty acids from purified phospholipids.Clin Nutr. 2001 Feb;20(1):69-76. doi: 10.1054/clnu.2000.0163. Clin Nutr. 2001. PMID: 11161546 Clinical Trial.
-
Feeding a formula supplemented with long chain polyunsaturated fatty acids modifies the "ex vivo" cytokine responses to food proteins in infants at low risk for allergy.Pediatr Res. 2008 Oct;64(4):411-7. doi: 10.1203/PDR.0b013e318181b391. Pediatr Res. 2008. PMID: 18552712
-
Fatty acid profiles, antioxidant status, and growth of preterm infants fed diets without or with long-chain polyunsaturated fatty acids. A randomized clinical trial.Eur J Nutr. 2003 Oct;42(5):243-53. doi: 10.1007/s00394-003-0418-2. Eur J Nutr. 2003. PMID: 14569405 Clinical Trial.
-
[Long-chain polyunsaturated fatty acids in breast-fed and formula fed healthy infants].Orv Hetil. 1995 Mar 26;136(13):643-7. Orv Hetil. 1995. PMID: 7708393 Review. Hungarian.
-
[Importance of n-3 and n-6 fatty acids for visual function and development in newborn infants].Ugeskr Laeger. 1995 Apr 3;157(14):1987-91. Ugeskr Laeger. 1995. PMID: 7740636 Review. Danish.
Cited by
-
Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status.Matern Child Nutr. 2011 Apr;7 Suppl 2(Suppl 2):41-58. doi: 10.1111/j.1740-8709.2011.00303.x. Matern Child Nutr. 2011. PMID: 21366866 Free PMC article. Review.
-
Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial.Pediatrics. 2011 Sep;128(3):e505-12. doi: 10.1542/peds.2010-1386. Epub 2011 Aug 1. Pediatrics. 2011. PMID: 21807696 Free PMC article. Clinical Trial.
-
Prenatal Docosahexaenoic Acid Supplementation Does Not Affect Nonfasting Serum Lipid and Glucose Concentrations of Offspring at 4 Years of Age in a Follow-Up of a Randomized Controlled Clinical Trial in Mexico.J Nutr. 2017 Feb;147(2):242-247. doi: 10.3945/jn.116.238329. Epub 2016 Dec 21. J Nutr. 2017. PMID: 28003539 Free PMC article. Clinical Trial.
-
Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.Cochrane Database Syst Rev. 2016 Oct 28;10(10):CD010112. doi: 10.1002/14651858.CD010112.pub2. Cochrane Database Syst Rev. 2016. PMID: 27788565 Free PMC article.
-
Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial.BMJ Open. 2019 Sep 17;9(9):e030502. doi: 10.1136/bmjopen-2019-030502. BMJ Open. 2019. PMID: 31530611 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous